PMID- 31330263 OWN - NLM STAT- MEDLINE DCOM- 20200323 LR - 20200323 IS - 1096-1208 (Electronic) IS - 0882-4010 (Linking) VI - 136 DP - 2019 Nov TI - Characterization of the antioxidant and anti-inflammatory properties of a polysaccharide-based bioflocculant from Bacillus subtilis F9. PG - 103642 LID - S0882-4010(19)31089-7 [pii] LID - 10.1016/j.micpath.2019.103642 [doi] AB - Microbial flocculants are versatile class of novel biomacromolecules with numerous potential industrial applications. This study sought to investigate the antimicrobial, antioxidant, and anti-inflammatory potential of a polysaccharide-based bioflocculant (PBB) extracted from Bacillus subtilis F9. To achieve this, the antioxidant activity of different PBB concentrations(100 mug/mL ̶ 1000 mug/mL) was first examined in vitro using 2,2-diphenyl-1-picrylhydrazyl (DPPH), hydroxyl radicals, and superoxide radical scavenging assays. Further, the anti-inflammatory activity of PBB against lipopolysaccharide (LPS; 1 mug/mL)-induced inflammatory mediators released from headkidney (HK)-derived macrophages of Labeo rohita was investigated. Our results revealed that the capacities of 800 mug/mL of PBB to scavenge DPPH, hydroxyl radicals, and superoxide radicals were 81.46 +/- 1.37%, 66.34 +/- 2.63%, and 78.03 +/- 2.46%, respectively, which were slightly higher that observed following treatment with 400 mug/mL of the positive control (ascorbic acid). Further, the radical scavenging capacity of PBB was found to steadily increase with increasing concentrations of PBB. Pre-treatment with PBB also inhibited nitric oxide production in a dose-dependent manner. We next examined the effect of PBB on proinflammatory cytokines (TNF-alpha, and IL-1beta) and anti-inflammatory cytokines (IL-10, TGF-beta) via qRT-PCR and ELISA. We found that PBB markedly inhibited the LPS-induced mRNA and protein expression levels of TNF-alpha and IL-1beta, while it significantly increased those of IL-10 and TGF-beta. Further, PBB exhibited an antibacterial activity against multiple food-borne pathogens with minimal inhibitory concentration values in the range of 3 ̶ 11 mg/mL. Importantly, PBB exhibited negligible cytotoxic effects against HK macrophages. Taken together these results suggest that PBB may serve as a natural antioxidant for application in functional therapies and may also be exploited for its anti-inflammatory potential. CI - Copyright (c) 2019 Elsevier Ltd. All rights reserved. FAU - Giri, Sib Sankar AU - Giri SS AD - Laboratory of Aquatic Biomedicine, College of Veterinary Medicine and Research Institute for Veterinary Science, Seoul National University, Seoul, 08826, South Korea. Electronic address: giribiotek@gmail.com. FAU - Ryu, EunChae AU - Ryu E AD - Laboratory of Aquatic Biomedicine, College of Veterinary Medicine and Research Institute for Veterinary Science, Seoul National University, Seoul, 08826, South Korea. Electronic address: luckyvet@naver.com. FAU - Park, Se Chang AU - Park SC AD - Laboratory of Aquatic Biomedicine, College of Veterinary Medicine and Research Institute for Veterinary Science, Seoul National University, Seoul, 08826, South Korea. Electronic address: parksec@snu.ac.kr. LA - eng PT - Journal Article DEP - 20190719 PL - England TA - Microb Pathog JT - Microbial pathogenesis JID - 8606191 RN - 0 (Anti-Inflammatory Agents) RN - 0 (Antioxidants) RN - 0 (Cytokines) RN - 0 (Polysaccharides, Bacterial) RN - 11062-77-4 (Superoxides) RN - 31C4KY9ESH (Nitric Oxide) RN - 3352-57-6 (Hydroxyl Radical) SB - IM MH - Animals MH - Anti-Inflammatory Agents/*isolation & purification/*pharmacology MH - Antioxidants/*isolation & purification/*pharmacology MH - Bacillus subtilis/*chemistry MH - Cells, Cultured MH - Cyprinidae MH - Cytokines/metabolism MH - Hydroxyl Radical/metabolism MH - Macrophages/drug effects/metabolism MH - Nitric Oxide/metabolism MH - Polysaccharides, Bacterial/*isolation & purification/*pharmacology MH - Superoxides/metabolism OTO - NOTNLM OT - Antibacterial OT - Antioxidant OT - Polysaccharide-based bioflocculant EDAT- 2019/07/23 06:00 MHDA- 2020/03/24 06:00 CRDT- 2019/07/23 06:00 PHST- 2019/06/16 00:00 [received] PHST- 2019/07/04 00:00 [revised] PHST- 2019/07/19 00:00 [accepted] PHST- 2019/07/23 06:00 [pubmed] PHST- 2020/03/24 06:00 [medline] PHST- 2019/07/23 06:00 [entrez] AID - S0882-4010(19)31089-7 [pii] AID - 10.1016/j.micpath.2019.103642 [doi] PST - ppublish SO - Microb Pathog. 2019 Nov;136:103642. doi: 10.1016/j.micpath.2019.103642. Epub 2019 Jul 19.